［1］Weiss A，Leinwand LA. The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol，1996，12：417-439.

［2］Joseph L. Greenstein，Raimond L. Winslow. Integrative Systems Models of Cardiac Excitation-Contraction Coupling. Circ Res，2011，108（1）：70-84.

［3］Noah Weisleder，Jianjie Ma. Altered Ca ^2﹢ sparks in aging skeletal and cardiac muscle. Ageing Res Rev，2008，7（3）：177-188.

［4］Leybaert L，Sanderson MJ. Intercellular Ca ^2﹢ Waves：Mechanisms and Function. Physiol Rev，2012，92（3）：1359-1392.

［5］Fabiato A. Simulated calcium current can both cause calcium loading in and trigger calcium release from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol，1985，85（2）：291-320.

［6］Vasco Sequeira，Jolanda van der Velden. Historical perspective on heart function：the Frank-Starling Law. Biophys Rev，2015，7（4）：421-447.

［7］Mayra de A. Marques，Guilherme A. P. de Oliveira. Cardiac Troponin and Tropomyosin：Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype. Front Physiol，2016，7：429.

［8］Jennifer England，Siobhan Loughna. Heavy and light roles：myosin in the morphogenesis of the heart. Cell Mol Life Sci，2013，70（7）：1221-1239.

［9］Lowes BD，Minobe W，Abraham WT，et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied，failing ventricular myocardium. J Clin Invest，1997，100（9）：2315-2324.

［10］Miyata S，Minobe W，Bristow MR，et al. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res，2000，86（4）：386-390.

［11］Fatkin D，McConnell BK，Mudd JO，et al. An abnormal Ca ^2﹢response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest，2000，106（11）：1351-1359.

［12］Gupta MP. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol，2007，43（4）：388-403.

［13］Krenz M，Robbins J. Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol，2004，44（12）：2390-2397.

［14］Nakao K，Minobe W，Roden R，et al. Myosin heavy chain gene expression in human heart failure. J Clin Invest，1997，100（9）：2362-2370.

［15］Herron TJ，McDonald KS. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res，2002，90（11）：1150-1152.

［16］Schiaffino S，Reggiani C. Molecular diversity of myofibrillar proteins：gene regulation and functional significance. Physiol Rev，1996，76（12）：371-423.

［17］Luo X，Zhang H，Xiao J，et al. Regulation of human cardiac ion channel genes by microRNAs：theoretical perspective and pathophysiological implications. Cell Physiol Biochem，2010，25（6）：571-586.

［18］Berezikov E，Thuemmler F，van Laake LW，et al. Diversity of microRNAs in human and chimpanzee brain. Nat Genet，2006，38（12）：1375-1377.

［19］Landgraf P，Rusu M，Sheridan R，et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell，2007，129（7）：1401-1414.

［20］van Rooij E，Sutherland LB，Qi X，et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science，2007，316（5824）：575-579.

［21］Tatsuguchi M，Seok HY，Callis TE，et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol，2007，42（6）：1137-1141.

［22］Thum T，Galuppo P，Wolf C，et al. MicroRNAs in the human heart：a clue to fetal gene reprogramming in heart failure. Circulation，2007，116（3）：258-267.

［23］David M Patrick，Rusty L Montgomery，Xiaoxia Qi，et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest，2010，120（11）：3912-3916.

［24］Shuguang Dong，Wenhan Ma，Bohan Hao，et al. microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol，2014，7（2）：565-574.

［25］Zhu SM，Si ML，Wu HL，et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1（TPM1）. J Biol Chem，2007，282（19）：14328-14336.

［26］Latronico MV，Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol，2009，6（6）：419-429.

［27］Carè A，Catalucci D，Felicetti F，et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med，2007，13（5）：613-618.

［28］Steenaart NA，Ganim JR，Di Salvo J，et al. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch Biochem Biophys，1992，293（1）：17-24.

［29］Davare MA，Horne MC，Hell JW. Protein phosphatase 2A is associated with class C L-type calcium channels（Cav1.2）and antagonizes channel phosphorylation by cAMP-dependent protein kinase. J Biol Chem，2000，275（50）：39710-39717.

［30］Marx SO，Reiken S，Hisamatsu Y，et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel（ryanodine receptor）：defective regulation in failing hearts. Cell，2000，101（4）：365-376.

［31］Hall DD，Feekes JA，Arachchige Don AS，et al. Binding of protein phosphatase 2A to the L-type calcium channel Cav1.2 next to Ser1928，its main PKA site，is critical for Ser1928 dephosphorylation. Biochemistry，2006，45（10）：3448-3459.

［32］Terentyev D，Belevych AE，Terentyeva R，et al. miR-1 overexpression enhances Ca ^2﹢release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory. subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res，2009，104（4）：514-521.

［33］Nicolaou P，Hajjar RJ，Kranias EG. Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J Mol Cell Cardiol，2009，47（3）：365-371.

［34］Cai WF，Liu GS，Lam CK，et al. Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractility. Euro J heart failure，2015，17（8）：782-793.

［35］Takashima S. Phosphorylation of myosin regulatory light chain by myosin light chain kinase，and muscle contraction. Circ J，2009，73（2）：208-213.

［36］Maier LS，Bers DM. Calcium，calmodulin，and calcium-calmodulin kinaseⅡ：heartbeat to heartbeat and beyond. J Mol Cell Cardiol，2002，34（8）：919-939.

［37］Wahlquist C，Jeong D，Rojas-Muñoz A，et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature，2014，508（7497）：531-535.

［38］Jessup M，Greenberg B，Mancini D，et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease（CUPID）Investigators. Calcium Up regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease（CUPID）：a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca ^2﹢-ATPase in patients with advanced heart failure. Circulation，2011，124（3）：304-313.

［39］Xu M，Wu HD，Li RC，et al. Mir-24 regulates junctophilin-2 expression in cardiomyocytes. Circ Res，2012，111：837-841.

［40］Li RC，Tao J，Guo YB，et al. In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circulation research，2013，112（4）：601-605.